

Would allow the state’s Research Advisory Panel to apply to the United States FDA for permission to run clinical trials using psychedelic substances such as Psilocybin and Ibogaine on military veterans suffering from conditions like PTSD, depression, traumatic brain injuries, and substance use disorders that are linked to high suicide risk..
Subscribe to the Real Impact E-Newsletter to get our news and updates directly to your inbox.